|
Lopez-Galvez R, Marin F, Rivera-Caravaca JM. Predicting heart failure in atrial fibrillation patients: What about using biomarkers? Am Heart J. 2022 Sep;251:32-34. doi: 10.1016/j.ahj.2022.05.007. Epub 2022 May 7. No abstract available. PubMed PMID: 35537504.
AÑO: 2022; IF: 4.8
|
35537504
|
Esteve-Pastor MA, Rivera-Caravaca JM, Ruiz-Ortiz M, Muniz J, Roldan-Rabadan I, Otero D, Lopez-Galvez R, Cequier A, Bertomeu-Martinez V, Badimon L, Anguita M, Lip GYH, Marin F; FANTASIIA investigators. A comparison of front-line oral anticoagulants for the treatment of non-valvular atrial fibrillation: effectiveness and safety of direct oral anticoagulants in the FANTASIIA registry. Expert Opin Pharmacother. 2022 Aug;23(12):1457-1465. doi: 10.1080/14656566.2022.2109961. Epub 2022 Aug 12. PubMed PMID: 35924672.
AÑO: 2022; IF: 3.2
|
|
Lopez-Galvez R, Rivera-Caravaca JM, Roldan V, Orenes-Pinero E, Esteve-Pastor MA, Lopez-Garcia C, Saura D, Gonzalez J, Lip GYH, Marin F. Imaging in atrial fibrillation: A way to assess atrial fibrosis and remodeling to assist decision-making. Am Heart J. 2023 Apr;258:1-16. doi: 10.1016/j.ahj.2022.12.007. Epub 2022 Dec 13. PubMed PMID: 36526006.
AÑO: 2023; IF: 3.7
|
|
Lopez-Galvez R, Rivera-Caravaca JM, Mandaglio-Collados D, Orenes-Pinero E, Lahoz A, Hernandez-Romero D, Martinez CM, Carpes M, Arribas JM, Canovas S, Lip GYH, Marin F. Molecular mechanisms of postoperative atrial fibrillation in patients with obstructive sleep apnea. FASEB J. 2023 Jun;37(6):e22941. doi: 10.1096/fj.202201965RR. PubMed PMID: 37115741.
AÑO: 2023; IF: 4.4
|
|
Mandaglio-Collados D, Lopez-Galvez R, Ruiz-Alcaraz AJ, Lopez-Garcia C, Roldan V, Lip GYH, Marin F, Rivera-Caravaca JM. Impact of particulate matter on the incidence of atrial fibrillation and the risk of adverse clinical outcomes: A review. Sci Total Environ. 2023 Jul 1;880:163352. doi: 10.1016/j.scitotenv.2023.163352. Epub 2023 Apr 4. PubMed PMID: 37023806.
AÑO: 2023; IF: 8.2
|